Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $7.2850 (-2.08%) ($7.2850 - $7.2850) on Thu. Aug. 18, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.12% (three month average) | RSI | 65 | Latest Price | $7.2850(-2.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -0.6% a day on average for past five trading days. | Weekly Trend | TGTX advances 13.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) QQQ(99%) EWI(98%) ICLN(92%) XLK(90%) SPY(88%) | Factors Impacting TGTX price | TGTX will decline at least -3.56% in a week (0% probabilities). XOP(5%) OIH(14%) EDOC(28%) TBT(-34%) TIP(16%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.56% (StdDev 7.12%) | Hourly BBV | -0.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $7.84(-7.08%) | 10 Day Moving Average | $7.6(-4.14%) | 20 Day Moving Average | $6.92(5.27%) | To recent high | -13.5% | To recent low | 95% | Market Cap | $923m | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |